Hickey Benjamin
SEC CIK 1753055 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| BMY | Bristol Myers Squibb | Pres, RayzeBio Org | 18.3K | — | $3,702 | 9 | 2025-02-01 | 2026-02-27 |
Most active insiders at BMY, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Elkins David V | EVP, CFO | — | $1.85M |
| 2 | Massacesi Cristian | EVP, Chief Med Offr, Head of Dev | — | $403.5K |
| 3 | Holzer Phil M | SVP, Ctrl | — | $33.8K |
| 4 | Short Bartie Wendy | EVP, Corp. Affairs | — | — |
| 5 | Hoch Lynelle | Pres, Cell Therapy Org | — | — |
| 6 | Poole Ahn Amanda | EVP, CHRO | — | — |
| 7 | Gallman Cari | EVP, GC | — | — |
| 8 | Lenkowsky Adam | EVP, Chief Commercial Off | — | — |
| 9 | Shanahan Karin | EVP, Chief Supply Chain, Ops | — | — |
| 10 | Meyers Gregory Scott | EVP, Chief Digital, Tech Off | — | — |
| 12 | Hickey Benjamin | Pres, RayzeBio Org | — | — |
Transactions 9
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2026-03-03 | 2026-02-27 | BMY | Bristol Myers Squibb | Hickey Benjamin | Pres, RayzeBio Org | M - OptEx | $0.00 | +3,286 | 18.3K | +22% | $0 |
| D | 2026-03-03 | 2026-02-27 | BMY | Bristol Myers Squibb | Hickey Benjamin | Pres, RayzeBio Org | F - Tax | $62.37 | -1,672 | 16.7K | -9% | -$104.3K |
| D | 2026-02-03 | 2026-02-01 | BMY | Bristol Myers Squibb | Hickey Benjamin | Pres, RayzeBio Org | M - OptEx | $0.00 | +10.1K | 18.9K | +115% | $0 |
| D | 2026-02-03 | 2026-02-01 | BMY | Bristol Myers Squibb | Hickey Benjamin | Pres, RayzeBio Org | F - Tax | $55.05 | -3,810 | 15.1K | -20% | -$209.7K |
| I | 2025-05-13 | 2025-05-09 | BMY | Bristol Myers Squibb | Hickey Benjamin | Pres, RayzeBio Org | S - Sale | $38.01 | -97.39 | 0 | -100% | -$3,702 |
| D | 2025-03-04 | 2025-03-01 | BMY | Bristol Myers Squibb | Hickey Benjamin | Pres, RayzeBio Org | F - Tax | $59.62 | -1,630 | 8,789 | -16% | -$97.2K |
| D | 2025-03-04 | 2025-03-01 | BMY | Bristol Myers Squibb | Hickey Benjamin | Pres, RayzeBio Org | M - OptEx | $0.00 | +3,286 | 10.4K | +46% | $0 |
| D | 2025-02-04 | 2025-02-01 | BMY | Bristol Myers Squibb | Hickey Benjamin | Pres, RayzeBio Org | M - OptEx | $0.00 | +10.1K | 10.9K | +1,292% | $0 |
| D | 2025-02-04 | 2025-02-01 | BMY | Bristol Myers Squibb | Hickey Benjamin | Pres, RayzeBio Org | F - Tax | $58.95 | -3,725 | 7,133 | -34% | -$219.6K |
Purchase Sale Sale after option exercise All abbreviations